MedTrace Logo

Acid-suppressing Drugs Pregnancy Asthma Offspring Study

NCT01787435 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10116

Last updated 2015-04-06

No results posted yet for this study

Summary

The purpose of this study is

1. To estimate the association between prenatal exposure to proton pump inhibitors (PPIs) and the risk of asthma during childhood.
2. To estimate the association between prenatal exposure to H2-receptor antagonists (H2RAs) and the risk of asthma during childhood.

Conditions

  • Asthma in Offspring

Interventions

DRUG

Risk of asthma in offspring

Exposure to PPI or H2RA, respectively during pregnancy No exposure to acid suppressing drugs during pregnancy

Sponsors & Collaborators

Principal Investigators

  • Luis A Garcia Rodriguez, MD · CEIFE (Centro Espanol de Investigacion Farmacoepidemiologica - Spanish Centre for Pharmacoepidemiologic Research )

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01787435 on ClinicalTrials.gov